About the initiative
This initiative funds innovative, collaborative health technologies. It drives discoveries that address key health challenges towards proof-of-concept and commercialisation, maximising entrepreneurship and idea potential.
It now forms part of the Medical Research Commercialisation initiative.
Why it is important
This initiative is important because it develops Australia’s world-class research into real treatments, drugs and devices to benefit Australians.
It supports the Australian biomedical and medical technology sector to create new jobs and expertise.
The BioMedTech Horizons initiative aims to:
- develop new biomedical and medical innovation and technologies in Australia to benefit Australians
- grow our biomedical and medical technology sector so that Australia’s world-class research is developed into real treatments, drugs and devices
- boost employment and grow business in the biomedical and medical technology sector.
Meeting our goals
The Australian Government provides this funding through an agreement with MTPConnect. MTPConnect is an Industry Growth Centre — a not-for-profit organisation that drives innovation, productivity and competitiveness in the medical technologies, biotechnologies and pharmaceuticals sector.
MTPConnect will identify and select promising biomedical and medical technology initiatives and work in partnership to support their development. They focus on projects that are most likely to become successful products in the future.
Who works with us
The Australian Government’s Medical Research Future Fund (MRFF) funds this initiative.
MTPConnect administers the initiative.
The BioMedTech Horizons initiative now forms part of the Medical Research Commercialisation initiative.
For further information, contact MTPConnect.